Attached files
file | filename |
---|---|
EX-5.1 - OPINION LETTER - Mawson Infrastructure Group Inc. | fs12018a1ex5-1_wizepharmainc.htm |
S-1/A - AMENDMENT NO. 1 TO FORM S-1 - Mawson Infrastructure Group Inc. | fs12018a1_wizepharmainc.htm |
Exhibit 23.1
Fahn Kanne & Co. Head Office 32 Hamasger Street Tel-Aviv 6721118, ISRAEL PO Box 36172, 6136101
T +972 3 7106666 F +972 3 7106660 www.gtfk.co.il |
CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 28, 2018, with respect to the consolidated financial statements of Wize Pharma, Inc. contained in Amendment No. 1 to the Registration Statement on Form S-1 and Prospectus of Wize Pharma, Inc. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts”.
/s/ FAHN KANNE & CO. GRANT THORNTON ISRAEL
Tel-Aviv, Israel
Date May 10, 2018
Certified Public Accountants
Fahn Kanne & Co. is the Israeli member firm of Grant Thornton International Ltd.